|MMWR Weekly |
Volume 62, No. 45
November 15, 2013
PDF of this issue
Errata: Vol. 62, No. RR-7
WeeklyNovember 15, 2013 / 62(45);906
In the Recommendations and Reports, "Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014," three errors occurred.
On page 22, the last sentence of the third paragraph under the subheading "Fluarix Quadrivalent" should read, "Overall frequencies of most solicited adverse events associated with Fluarix Quadrivalent in these studies were generally similar to these reported for the comparator trivalent vaccines."
On page 23, the second sentence of the first paragraph under the subheading "Flulaval Quadrivalent" should read, "Flulaval Quadrivalent will be available alongside the trivalent formulation of Flulaval during the 2013–14 season."
On page 23, the third sentence of the second paragraph under the subheading "Flulaval Quadrivalent" should read, "Contraindications and precautions to the administration of Flulaval Quadrivalent are similar to those described for the trivalent formulation of Flulaval (see Contraindications and Precautions for the Use of IIV; Table 2) (345)."